SCHEMBL13230883

SCHEMBL13230883

c1ccc(-c2ccccc2-c2c3ccccc3c(N(c3ccccc3)c3ccc4ccccc4n3)c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCF1 P14598 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ ATM Q13315 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ PDE5A O76074 2/20 0.33
▸ ESR1 P03372 2/20 0.33
▸ ESR2 Q92731 2/20 0.33
▸ PTGS2 P35354 1/20 0.33
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13230742 0.89 NCF1 (0.42) NCF1ALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL13231180 0.89 NCF1 (0.38) NCF1ALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL13230772 0.88 KMT2A (0.40) NCF1ALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL13230948 0.87 NCF1 (0.41) NCF1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL13250585 0.86 NCF1 (0.50) NCF1ALDH1A1KDM4ETDP1NPC1
SCHEMBL13230848 0.85 NCF1 (0.39) NCF1ALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL13230977 0.85 NCF1 (0.39) NCF1ALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL13230913 0.84 NCF1 (0.38) NCF1ALDH1A1L3MBTL1KDM4ETDP1
SCHEMBL13230812 0.82 NCF1 (0.39) NCF1ALDH1A1KDM4ENPC1RAB9A
SCHEMBL13230900 0.81 MEN1 (0.39) KDM4ERAB9AMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100164371-A1 ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-07-01 — — US disclosed
US-20100164371-A1 ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG. DISPLAY CO. LTD. (KR) 2010-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100164371-A1 ELECTRON TRANSPORTING-INJECTION COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLCO4C1, SLCO2A1, SLCO2B1 NCF1 1982/4885ALDH1A1 539/4885L3MBTL1 2739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback